We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo ADLM 2025 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Suppression of DNA Repair by H. pylori Paves the Way for Development of Gastric Cancer

By LabMedica International staff writers
Posted on 28 Jun 2015
Image: The stomach bacterium Helicobacter pylori changes the activity of genes in gastric cells (Photo courtesy of Max Planck Institute for Infection Biology).
Image: The stomach bacterium Helicobacter pylori changes the activity of genes in gastric cells (Photo courtesy of Max Planck Institute for Infection Biology).
A team of molecular microbiologists has established what they believe to be the definitive link between Helicobacter pylori infection and the development of gastric cancer.

Infection with the human pathogen H. pylori is a major risk factor for gastric cancer. However, since the bacterium exerts multiple genotoxic effects, investigators at the Max Planck Institute for Infection Biology (Berlin, Germany) chose to examine how DNA damage accumulated in gastric cells following H. pylori infection.

The investigators utilized a new technique for cultivating cultures of normal human stomach tissue. This material replaced the use of cancer cell lines whose mutated genomes obscured early changes induced by H. pylori.

Results published in the June 11, 2015, online edition of the journal Cell Reports revealed that the activity of several sub-telomeric genes responsible for recognizing and repairing damaged DNA was suppressed during the course of the infection. Infection impaired several host cell DNA repair factors, the extent of which depended on a functional H. pylori cag pathogenicity island (cagPAI). This led to accumulation of a unique DNA damage pattern, preferentially in transcribed regions and proximal to telomeres, in both gastric cell lines and primary gastric epithelial cells. The observed pattern correlated with focal amplifications in adenocarcinomas of the stomach and partly overlapped with known cancer genes.

They authors described their interpretation of the impact of H. pylori infection on host cell DNA by saying, "We thus demonstrate an impact of a bacterial infection directed toward specific host genomic regions and describe underlying characteristics that make such regions more likely to acquire heritable changes during infection, which could contribute to cellular transformation."

Related Links:

Max Planck Institute for Infection Biology


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Silver Member
Quality Control Material
Multichem ID-B
New
Pan-Cancer Panel
TruSight Oncology 500

DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: Brain biomarkers of Alzheimer\'s disease can be detected as early as middle age (Photo courtesy of University of Shutterstock)

Blood-Based Biomarkers Could Detect Alzheimer's as Early as Middle Age

As the global population ages, Alzheimer's disease and other dementing diseases are becoming more prevalent. The disease processes leading to Alzheimer's symptoms can begin years or even decades before... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: Micrograph showing the distribution of misfolded proteins in myeloma cells (Photo courtesy of Helmholtz Munich)

Novel Method Tracks Cancer Treatment in Cells Without Dyes or Labels

Multiple myeloma is a blood cancer that affects plasma cells in the bone marrow, leading to abnormal protein production, weakened immunity, and organ damage. Traditional methods for evaluating myeloma... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
PURITAN MEDICAL